Congress Materials – Psych Elevate 2025
2025 Psych Elevate | May 28-31 | Las Vegas, NV
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Association of Antipsychotic Medication Nonadherence With All-Cause Mortality in Newly Treated Adults With Schizophrenia: A Retrospective Healthcare Claims Study
Christoph U. Correll, Brahim K. Bookhart, Carmela Benson, Zhiwen Liu, Zhongyun Zhao, Wenze Tang
Change in Clinician-Rated and Patient-Reported Depression Severity After Esketamine Nasal Spray as Monotherapy in Adult Patients With Treatment-Resistant Depression: A Post Hoc Analysis of Item Scores
Richard Shelton, Mai Himedan, Dong-Jing Fu, Ibrahim Turkoz, Amit Patel, Lisa Lim, Oliver Lopena
Earlier Use of Long-Acting Injectable Paliperidone Palmitate versus Oral Antipsychotics in Patients With Schizophrenia: A Post-hoc Analysis From PROSIPAL
Rebecca Roma, Nia Josiah, Monica Doring, Lisa Lim, Camilo Obando, Ibrahim Turkoz, James Simples Jr., Karen Johnston, Tyler Casey, Martha Sajatovic
Efficacy and Safety of Esketamine Nasal Spray as Monotherapy in Adult Patients With Treatment-Resistant Depression for up to 4 Months of Treatment: A Post Hoc Analysis
Andrew J Cutler, Dong-Jing Fu, Ibrahim Turkoz, Mai Himedan, Oliver Lopena, Lisa Lim, John S Verbanac
Longitudinal Real-World Study of the Patient Journey of a National Sample of Beneficiaries With Schizophrenia Dually Eligible for Medicare & Medicaid
Pengxiang Li, Zhi Geng, Carmela Benson, Charmi Patel, Jalpa A. Doshi
Long-Term Efficacy and Safety of Esketamine Nasal Spray as Monotherapy: A Post Hoc Analysis of the SUSTAIN-3 Study
John Zajecka, Dong-Jing Fu, Ibrahim Turkoz, Patricia Cabrera, Oliver Lopena, Lisa Lim, Megan Kunka Fritz, Muhammad Ahmed
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.